{
    "clinical_study": {
        "@rank": "55221", 
        "acronym": "LINET", 
        "arm_group": [
            {
                "arm_group_label": "DALI-adsorber, hypercholesterolemia", 
                "description": "Patients suffering from familial hypercholesterolemia treated at least twice a month with the DALI-system"
            }, 
            {
                "arm_group_label": "MONET-Filter, hypercholesterolemia", 
                "description": "Patients suffering from familial hypercholesterolemia treated with the MONET-Lipoprotein filter"
            }
        ], 
        "brief_summary": {
            "textblock": "Low Density Lipoprotein (LDL)-apheresis refers to a procedure in which blood taken from a\n      patient's vein is cleaned from pathogenic substances, e.g. cholesterol, outside the body and\n      then given back to the patient. In the DALI (Direct Adsorption of Lipoproteins)-system whole\n      blood is pumped over an adsorber containing beads that selectively bind LDL-cholesterol. The\n      MONET (Membrane filtration Optimized Novel Extracorporeal Treatment)-system works with\n      plasma which is cleaned by filtration. This study comprises the recording of safety and\n      efficacy data from patients treated either with the DALI or MONET-system over a period of 2\n      years."
        }, 
        "brief_title": "Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hypercholesterolemia, Familial", 
            "LIPOPROTEIN TYPES--Lp SYSTEM Lp(a) HYPERLIPOPROTEINEMIA"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypercholesterolemia", 
                "Hyperlipoproteinemia Type II", 
                "Hyperlipoproteinemias"
            ]
        }, 
        "detailed_description": {
            "textblock": "Data were recorded from patients suffering from familial hypercholesterolemia and treated by\n      lipid apheresis using one of the two systems investigated for at least 3 months prior to\n      inclusion in the study. Only those treatments were documented in which routine blood samples\n      for laboratory analysis were taken, or in which adverse or serious adverse device effects\n      occur."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  given informed consent\n\n          -  18 years or older\n\n          -  patient compliant to therapy as prescribed\n\n          -  at least two therapy sessions per month\n\n          -  treatment with DALI or MONET system for at least 3 months before inclusion\n\n          -  last severe invasive intervention in hospital more than 3 months ago\n\n        Exclusion Criteria:\n\n          -  earlier participation in the study\n\n          -  unconscious patient/persons without capacity to contract\n\n          -  for DALI: intake of ACE-inhibitors"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Hypercholesterolemic patients from free-standing private apheresis centres and one\n        hospital department"
            }
        }, 
        "enrollment": {
            "#text": "108", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01753232", 
            "org_study_id": "TA-DALI-MONET-01-D"
        }, 
        "intervention": [
            {
                "arm_group_label": "DALI-adsorber, hypercholesterolemia", 
                "description": "Recording of treatment data. No extra interventional treatment", 
                "intervention_name": "DALI-adsorber", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "MONET-Filter, hypercholesterolemia", 
                "description": "Only treatment data recording. No extra interventional treatment", 
                "intervention_name": "MONET-Lipoprotein filter", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "DALI adsorber", 
            "MONET lipoprotein filter"
        ], 
        "lastchanged_date": "December 20, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Mannheim", 
                        "country": "Germany", 
                        "state": "Baden W\u00fcrtemberg", 
                        "zip": "68309"
                    }, 
                    "name": "Nierenzentrum Mannheim"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kempten", 
                        "country": "Germany", 
                        "state": "Bayern", 
                        "zip": "87439"
                    }, 
                    "name": "Medizinisches Versorgungszentrum"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Regensburg", 
                        "country": "Germany", 
                        "state": "Bayern", 
                        "zip": "93053"
                    }, 
                    "name": "Universit\u00e4tsklinikum Regensburg Institut f\u00fcr Klinische Chemie und Laboratoriumsmedizin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Potsdam", 
                        "country": "Germany", 
                        "state": "Brandenburg", 
                        "zip": "14482"
                    }, 
                    "name": "Dialysezentrum Potsdam"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rostock", 
                        "country": "Germany", 
                        "state": "Mecklenburg-Vorpommern", 
                        "zip": "18059"
                    }, 
                    "name": "Apheresezentrum Rostock"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Goettingen", 
                        "country": "Germany", 
                        "state": "Niedersachsen", 
                        "zip": "37075"
                    }, 
                    "name": "Nephrologisches Zentrum Goettingen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "state": "Niedersachsen", 
                        "zip": "30625"
                    }, 
                    "name": "Zentrum f\u00fcr Nieren und Hochdruckkrankheiten Standort Heidering"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Essen", 
                        "country": "Germany", 
                        "state": "Nordrhein Westfalen", 
                        "zip": "45127"
                    }, 
                    "name": "Nephrologische Gemeinschaftspraxis Dialysezentrum/Lipidzentrum"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f6ln", 
                        "country": "Germany", 
                        "state": "Nordrhein-Westfalen", 
                        "zip": "51105"
                    }, 
                    "name": "Gemeinschaftspraxis Gysan, Heinzler, May, Hossmann"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ingelheim", 
                        "country": "Germany", 
                        "state": "Rheinland Pfalz", 
                        "zip": "55218"
                    }, 
                    "name": "Apheresezentrum Ingelheim"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Magdeburg", 
                        "country": "Germany", 
                        "state": "Sachsen Anhalt", 
                        "zip": "39108"
                    }, 
                    "name": "Dialysezentrum Magdeburg-Stattfeld"
                }
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "2", 
        "official_title": "Non-interventional Study: Safety and Efficacy of the DALI LDL-adsorber and MONET-lipoprotein Filter", 
        "overall_official": [
            {
                "affiliation": "Gemeinschaftspraxis Gysan, Heinzler, May, Hossmann", 
                "last_name": "Rainer Heinzler, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Dres. Heigl, Hettich & Partner Medizinisches Versorgungszentrum", 
                "last_name": "Franz Heigl, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Nierenzentrum Mannheim", 
                "last_name": "Frank Leistikow, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Apheresezentrum Ingelheim", 
                "last_name": "Frido Himmelsbach, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Nephrologische Gemeinschaftspraxis Dialysezentrum/Lipidzentrum", 
                "last_name": "Ralf Spitth\u00f6ver, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Zentrum f\u00fcr Nieren,- Hochdruck und Stoffwechselerkrankungen Standort Heidering", 
                "last_name": "Eberhard Roeseler, MD, Prof", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Nephrologisches Zentrum Goettingen", 
                "last_name": "Volker Schettler, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University Regensburg Department Clinical Chemistry and Laboratory Medicine", 
                "last_name": "Gerd Schmitz, MD, Prof", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Dialysezentrum Magdeburg-Stadtfeld", 
                "last_name": "Nadim Abduhl-Rahman, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Dialysezentrum Potsdam", 
                "last_name": "Jens Ringel, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Apheresezentrum Rostock", 
                "last_name": "Wolfgang Ramlow, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Data are only recorded for visits with lab results", 
            "measure": "Change of Low Density Lipoprotein (LDL)-Concentration", 
            "safety_issue": "No", 
            "time_frame": "Every two weeks to every three months for 24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01753232"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Blood/plasma volume treated", 
                "safety_issue": "No", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "measure": "Number of occurence of adverse and serious adverse device effects", 
                "safety_issue": "Yes", 
                "time_frame": "24 months"
            }, 
            {
                "description": "Only in patients with isolated Lp(a) increase", 
                "measure": "Change of Lipoprotein(a)-concentration", 
                "safety_issue": "No", 
                "time_frame": "Pre/post treatment over 24 months, once per month or every 3 months"
            }, 
            {
                "description": "Only for treatment sessions with lab results", 
                "measure": "Change of total cholesterol", 
                "safety_issue": "No", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "description": "Only for treatment sessions with lab results", 
                "measure": "Change of High Density Lipoprotein (HDL)-concentration", 
                "safety_issue": "No", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "description": "Only for treatment sessions with lab results", 
                "measure": "Change of triglyceride-concentration", 
                "safety_issue": "No", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "description": "Only for treatment sessions with lab results", 
                "measure": "Change in blood count", 
                "safety_issue": "Yes", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "description": "Only for treatment sessions with lab results", 
                "measure": "Change of fibrinogen-concentration", 
                "safety_issue": "Yes", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "measure": "Change of creatinine-concentration", 
                "safety_issue": "Yes", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "description": "Only for treatment sessions with lab results, Immunoglobulin (Ig) G, IgA and IgM if measured. In MONET patients only.", 
                "measure": "Change of Immunoglobulins (Ig)", 
                "safety_issue": "Yes", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "description": "Only for treatment sessions with lab results", 
                "measure": "Change in C Reactive Protein (CRP)-concentration", 
                "safety_issue": "Yes", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "description": "Only for treatment sessions with lab results", 
                "measure": "Change of blood pressure and heart rate", 
                "safety_issue": "Yes", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "measure": "Blood or plasma flow", 
                "safety_issue": "No", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "measure": "Anticoagulation regime", 
                "safety_issue": "No", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "measure": "Treatment time", 
                "safety_issue": "No", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }, 
            {
                "measure": "Medication", 
                "safety_issue": "No", 
                "time_frame": "Every two weeks to every three months for 24 months"
            }
        ], 
        "source": "Fresenius Medical Care Deutschland GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fresenius Medical Care Deutschland GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}